joint pain glp-1 How a discovery in fluid could change the way we treat arthritis Do GLP-1 drugs ease arthritis

En muchos pacientes, s ayudan a reducir el hambre

CLINICAL TRIAL EVIDENCE FOR GLP-1 RAs IN MASH Table 2 provides a summary of phase 2 and phase 3 studies examining GLP-1 RAs and dual or triple agonists (aiming glucagon, GIP, and GLP-1 receptors) in individuals with MASLD/MASH, where hepatic biopsies were used to evaluate liver outcomes [3,5,10,11,15,22-25,44-52]

doi: 10.1172/JCI24422 65 HaeberleHATakizawaRCasolaABrasierARDieterichHJvan RooijenNet al

Christian Wber: has received honoraria consultancy/speaking from Apomedica, Curelator, Eli Lilly, Grnenthal, Hermes, Lundbeck, Novartis, Pfizer, Ratiopharm/Teva, and Stada

Thc phm, ung Trong ngnh F&B trn th gii ang dn p dng thnh phn KSM-66 Ashwagandha vo trong cc loi thc phm, ung hoc cc loi cng thc ch bin gia tng gi tr ca sn phm bi nhng li ch v cng ton din m KSM-66 Ashwagandha mang li

Research by Richie et al